
Nasal sprays could be the future of treatment for Parkinson’s disease
Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson’s disease.
Researchers have developed a new gel that can adhere to tissue inside the nose alongside the drug levodopa, helping deliver treatment directly to the brain.
Levodopa is converted to dopamine in the brain, which makes-up for the deficit of dopamine-producing cells in Parkinson’s patients, and helps treat the symptoms of the disease. Over extended periods of time, however, levodopa becomes less effective, and increased doses are needed.
Increased dosage
Professor David Smith, from the University of York’s Department of Chemistry, said: “The current drug used for Parkinson’s Disease is effective to a point, but after a long period of use the body starts to breakdown the drug before it gets to the brain where it is most needed.
“This means increased dosage is necessary, and in later stages, sometimes, instead of tablets, the drug has to be injected. Investigations into nasal sprays have long been of interest as a more effective delivery because of its direct route to the brain via the nerves that service the nose, but the challenge here is to find a way of making it adhere to the nasal tissue long enough to release a good dosage of the drug.”
The researchers created a gel, loaded with levodopa, that could flow into the nose as a liquid and then rapidly change to a thin layer of gel inside the nose. The method was tested in animal models by a team at King’s College London, where levodopa was successfully released from the gel into the blood and directly to the brain.
Better uptake
Professor Smith said: “The results indicated that the gel gave the drug better adhesion inside the nose, which allowed for better levels of uptake into both the blood and brain.”
The team are now working to incorporate these materials in nasal spray devices to progress to clinical trials in humans. The approach may also be relevant to other neurodegenerative diseases such as Alzheimer’s.
Khuloud Al-Jamal, Professor of Drug Delivery and Nanomedicine from King’s College London, said: “Not only did the gel perform better than a simple solution, but the brain uptake was better than that achieved using intravenous injection of the drug. This suggests that nasal delivery of Parkinson’s drugs using this type of gel may have clinical relevance.”
Original Article: Step-closer to nasal spray drug delivery for Parkinson’s disease
More from: University of York | King’s College London
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Nasal spray drug delivery
- Viagra replacement gets $10.5m funding boost
Brisbane-based LTR Pharma has attracted some big bucks from new investors as it seeks to replace the little blue pill in the bedroom with a simple nasal spray.
- P.E.I. advocacy group looks to add more doses, nasal spray option to take-home naloxone kits
PEERS Alliance says many people are more comfortable administering a nasal spray than injecting someone with a needle.
- Brain parasites found in cat poo could be ‘trained to spit out special proteins’ to TREAT Alzheimer’s and Parkinson’s
A PARASITE found in soiled cat litter could be used to treat Alzheimer’s and Parkinson’s, scientists say. Researchers discovered that Toxoplasma gondii – commonly present in ...
- Nasal spray clears proteins linked to Alzheimer’s – new study
Tau protein has long been associated with Alzheimer’s, but it’s hard to get rid of as it resides inside brain cells.
- Single-dose nasal spray ‘washes the brain’ of toxic Alzheimer’s proteins – paving the way for breakthrough treatment
A SINGLE-dose nasal spray treatment could ‘wash away’ build ups of toxic proteins associated with Alzheimer’s disease from brain cells and improve memory, scientists say. The study ...
Go deeper with Google Headlines on:
Nasal spray drug delivery
[google_news title=”” keyword=”nasal spray drug delivery” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Parkinson’s Disease
- Health Spotlight | Stop the shaking with a Parkinson’s patch
Parkinson’s — it’s the most common motor disorder and second most frequently diagnosed neurodegenerative disease, second only to Alzheimer’s.
- Kyle Connor's Parkinson's Awareness Cycling Tour Stops in at Assiniboine Park
A joint initiative of Winnipeg Jets forward Kyle Connor and Amazing Race Canada's Tim Hague, the first annual Team 81 U-Turn PD Ride for Parkinson's, is an endeavour set out to raise funds and ...
- Other Views: A hopeful step for Parkinson's patients
It began with a teacup and saucer at a work event. It was 2010, and Sherrie Pugh picked up the offending objects, but, before she could get coffee, the uncontrollable ...
- Higher-than-expected rate of gene mutations seen in Parkinson's patients
A higher-than-expected prevalence of gene mutations in Parkinson’s disease patients suggests genetic testing should be offered to them more broadly, researchers said on Monday in the medical journal ...
- Fecal Transplant a New Approach for Parkinson's Disease?
Although a new placebo-controlled trial failed to show symptom improvement, it yielded some interesting insights that may help in the design of future studies.
Go deeper with Google Headlines on:
Parkinson’s Disease
[google_news title=”” keyword=”Parkinson’s Disease” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]